- Home
- STTK vs TWIN Comparison
STTK vs TWIN Comparison
Compare STTK & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- TWIN
- Stock Information
- Founded
- STTK 2016
- TWIN 1918
- Country
- STTK United States
- TWIN United States
- Employees
- STTK N/A
- TWIN N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- TWIN Industrial Machinery/Components
- Sector
- STTK Health Care
- TWIN Industrials
- Exchange
- STTK Nasdaq
- TWIN Nasdaq
- Market Cap
- STTK 173.6M
- TWIN 169.9M
- IPO Year
- STTK 2020
- TWIN N/A
- Fundamental
- Price
- STTK $3.65
- TWIN $12.29
- Analyst Decision
- STTK Strong Buy
- TWIN
- Analyst Count
- STTK 3
- TWIN 0
- Target Price
- STTK $10.67
- TWIN N/A
- AVG Volume (30 Days)
- STTK 122.9K
- TWIN 20.1K
- Earning Date
- STTK 11-07-2024
- TWIN 10-31-2024
- Dividend Yield
- STTK N/A
- TWIN 1.29%
- EPS Growth
- STTK N/A
- TWIN 5.33
- EPS
- STTK N/A
- TWIN 0.79
- Revenue
- STTK $4,123,999.00
- TWIN $295,127,000.00
- Revenue This Year
- STTK $164.45
- TWIN N/A
- Revenue Next Year
- STTK N/A
- TWIN N/A
- P/E Ratio
- STTK N/A
- TWIN $15.73
- Revenue Growth
- STTK 380.09
- TWIN 6.56
- 52 Week Low
- STTK $1.33
- TWIN $10.90
- 52 Week High
- STTK $11.76
- TWIN $18.00
- Technical
- Relative Strength Index (RSI)
- STTK 50.03
- TWIN 46.94
- Support Level
- STTK $3.63
- TWIN $11.50
- Resistance Level
- STTK $3.94
- TWIN $12.85
- Average True Range (ATR)
- STTK 0.23
- TWIN 0.49
- MACD
- STTK 0.04
- TWIN 0.03
- Stochastic Oscillator
- STTK 49.12
- TWIN 45.66
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its products portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.